Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

COSM

Cosmos Health Inc

Jul 26 • 04:00PM ET

1.17

Dollar change -0.11
Percentage change -8.59	%

Healthcare • Medical Distribution • Greece • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: VXF

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-4.22	Insider Own	9.16%	Shs Outstand	16.93M	Perf Week	-5.65%
Market Cap	19.81M	Forward P/E	-	EPS next Y	-	Insider Trans	4.02%	Shs Float	15.38M	Perf Month	81.40%
Income	-42.91M	PEG	-	EPS next Q	-	Inst Own	3.57%	Short Float	1.85%	Perf Quarter	126.35%
Sales	49.59M	P/S	0.40	EPS this Y	-	Inst Trans	-97.68%	Short Ratio	0.14	Perf Half Y	10.90%
Book/sh	3.41	P/B	0.34	EPS next Y	-	ROA	-26.64%	Short Interest	0.28M	Perf Year	-28.22%
Cash/sh	0.14	P/C	8.32	EPS next 5Y	-	ROE	-64.96%	52W Range	0.47 - 2.05	Perf YTD	-17.02%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-22.04%	ROI	-88.17%	52W High	-42.93%	Beta	3.14
Dividend TTM	-	Quick Ratio	1.79	Sales past 5Y	-	Gross Margin	7.27%	52W Low	150.16%	ATR (14)	0.16
Dividend Ex-Date	-	Current Ratio	2.06	EPS Y/Y TTM	90.92%	Oper. Margin	-31.64%	RSI (14)	54.04	Volatility	11.42% 18.74%
Employees	-	Debt/Eq	0.24	Sales Y/Y TTM	-8.97%	Profit Margin	-86.53%	Recom	1.00	Target Price	4.00
Option/Short	Yes / Yes	LT Debt/Eq	0.09	EPS Q/Q	86.15%	Payout	-	Rel Volume	0.12	Prev Close	1.28
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	6.72%	Earnings	-	Avg Volume	2.10M	Price	1.17
SMA20	-0.74%	SMA50	32.72%	SMA200	26.15%	Trades		Volume	255,639	Change	-8.59%

Jul-25-24 02:45PM	Cosmos Health Successfully Submits Tender for C-Scrub Wash Chlorhexidine 4% to Supply NHS Scotland (ACCESSWIRE) +5.79%
11:40AM	Cosmos Health Signs Distribution Agreement with ProMed Trading for Its Sky Premium Life Food Supplements in Qatar (ACCESSWIRE)
Jul-24-24 10:55AM	Cosmos Health Updates on Contract Manufacturing Division; Completes Phase I of Production Capacity Expansion, Positioned to Generate Over $10M in Annual Gross Profit at Full Capacity (ACCESSWIRE)
Jul-19-24 11:40AM	Cosmos Health Regains Compliance with Nasdaq Minimum Bid Price Rule (ACCESSWIRE)
Jul-18-24 03:45PM	Cosmos Health's Cana Secures Additional Contract Manufacturing Agreement with Provident Pharmaceuticals for 700,000 Units, Bringing Total Order Book to 5.02 Million Units (ACCESSWIRE) -10.36%
03:45PM	Loading…
Jul-10-24 03:45PM	Cosmos Health Advances Commercialization of CCX0722 Weight Management Solution with Completion of Pilot Production and Scale-Up Phases; Significant Step Towards Entering $143Bn Global Market (ACCESSWIRE)
Jul-09-24 02:00PM	Cosmos Health's Cana Secures Contract Manufacturing Agreement with Australia's Humacology for up to 500,000 CBD Units Annually (ACCESSWIRE)
Jul-03-24 01:05PM	Cosmos Health's Cana Laboratories Completes Facility Upgrades and Secures Contract Manufacturing Agreement with Provident Pharmaceuticals for 4.32 Million Vials of DE3-SOLE (ACCESSWIRE) -10.89%
Jul-02-24 03:30PM	Cosmos Health Expands Collaboration with Papaellinas in Cyprus; Sky Premium Life Sales Expected to More Than Double to 150,000 Units Over Next 12 Months (ACCESSWIRE) -8.18%
Jul-01-24 11:20AM	Cosmos Health Signs Distribution Agreement with ZENDON s.r.o. in Slovakia, Hungary, Poland, and Czechia for Its Sky Premium Life Nutraceutical Products; Gains Access to More than 6,000 Stores of Leading Pharmacy and Retail Chains (ACCESSWIRE) +5.77%
Jun-28-24 08:12AM	Why Is Cosmos Health (COSM) Stock Up 65% Today? (InvestorPlace) +53.17%
07:39AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday (InvestorPlace)
Jun-27-24 03:45PM	Cosmos Health Signs Exclusive Distribution Agreement with Pharmalink for Its Sky Premium Life Nutraceuticals in the UAE; Receives Initial Purchase Order for 130,000 Units (ACCESSWIRE) +5.27%
Jun-18-24 10:00AM	Cosmos Health Strengthens Global Brain Tumor Market Position by Entering Agreement to Acquire Remaining Rights to WIPO-Filed CNS Cancer Drug Patent (ACCESSWIRE)
Jun-13-24 09:25AM	Cosmos Health Completes Acquisition of Pelofarm's Pharmacy Distribution Network; Annual Revenue Poised to Grow by Over $5 Million (ACCESSWIRE)
04:30PM	Loading…
May-24-24 04:30PM	Cosmos Health Receives Additional Delinquency Letter from Nasdaq Regarding Late Filings of Its Forms 10-K and 10-Q (ACCESSWIRE) +5.87%
May-17-24 10:15AM	Cosmos Health Participated in Vitafoods Europe 2024; Receives Significant Interest and Numerous New Partnership Inquiries for its Sky Premium Life Nutraceuticals Brand (ACCESSWIRE)
Apr-30-24 09:42AM	Stock Market Crash Warning: Don't Get Caught Holding These 3 Healthcare Stocks (InvestorPlace)
Apr-19-24 04:30PM	Cosmos Health Receives Nasdaq Notice on Late Filing of Its Form 10-K (ACCESSWIRE) -20.39%
Mar-21-24 09:45AM	Cosmos Health Commences Development of Cloudscreen 2.0, the New Iteration of its Next Generation AI Drug Repurposing Platform (ACCESSWIRE) -7.78%
Mar-19-24 10:10AM	Cosmos Health To Receive Regulatory Approval for C-Scrub Disinfectant in the UK, Obtains Initial Purchase Order; Explores Opportunities Outside EU, Eyeing Global $36Bn+ Market (ACCESSWIRE)
Mar-18-24 09:25AM	Cosmos Health Receives Regulatory Approval to Sell Sky Premium Life Products in $1.9Bn UAE Nutritional Supplements Market; Secures Initial Purchase Orders (ACCESSWIRE) -5.34%
Feb-29-24 09:25AM	Cosmos Health Successfully Completes Acquisition of Pharmatrade's Assets; Expects to Increase FY 2024 Annual Revenue by over $5 Million (ACCESSWIRE)
Feb-23-24 12:00AM	As Trading Frenzies Grip Penny Stocks, Criticism of Nasdaq Grows (The Wall Street Journal)
Feb-21-24 11:50AM	Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price (ACCESSWIRE)
09:30AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (GlobeNewswire)
Feb-20-24 09:25AM	Cosmos Health CEO, Greg Siokas, Purchases Shares in the Open Market, Showcasing His Confidence in the Company (ACCESSWIRE)
Feb-01-24 09:25AM	Taglich Brothers Initiates Coverage of Cosmos Health Inc. (ACCESSWIRE)
Jan-23-24 01:05PM	Cosmos Health Completes Acquisition of Cloudscreen, a Cutting-Edge AI Platform; Enters Lucrative $25Bn+ Global Drug Repurposing Market (ACCESSWIRE)
Jan-18-24 09:25AM	Cosmos Health Bolsters Presence in $400Bn+ Global Generic Drugs Market with $3.5M Acquisition of 10-Drug Portfolio (ACCESSWIRE)
09:27AM	Loading…
Dec-27-23 09:27AM	Cosmos Health Set for Substantial Growth From Acquisitions Completed in 2023 (ACCESSWIRE) +10.07%
Dec-20-23 09:15AM	Cosmos Health Enters into Definitive Agreement to Acquire Type-2 Diabetes Treatment DIABIT-IS X (ACCESSWIRE) -12.33%
Dec-18-23 09:15AM	Cosmos Health Announces Open Market Stock Purchases by the CEO (ACCESSWIRE) +8.49%
Dec-08-23 12:45PM	Cosmos Health to Participate at Capital Links 'Invest in Greece' Forum in New York (ACCESSWIRE) -7.89%
Dec-07-23 09:35AM	Cosmos Health Enters into Agreement to Acquire Rights for WIPO-Filed Patent on Drug Targeting CNS Cancers (ACCESSWIRE) +11.76%
Dec-01-23 10:25AM	Cosmos Health Announces Patent Filing for its Obesity and Weight Management Product (ACCESSWIRE) +8.65%
Nov-21-23 09:00AM	Cosmos Health Reports Q3 2023 Results; Revenue Increased 7% YoY, Total Assets Reached Record $71.5M with Stockholders' Equity of $44.2M or $3.4/Share (ACCESSWIRE) -6.36%
Oct-11-23 09:35AM	Cosmos Health to Acquire Cloudscreen, a Cutting-Edge AI-Powered Drug Repurposing Platform; Anticipated to Establish Cosmos as a Leader in the $25Bn Global Market and Deliver Unparalleled Returns for Shareholders (ACCESSWIRE) +12.71%
Oct-05-23 08:30AM	COSMOS HEALTH CEO Issues Letter to Shareholders (ACCESSWIRE)
Sep-27-23 10:30AM	Cosmos Health Actively Exploring Spinoff of R&D Division into a Publicly Listed Standalone Biotech Company (ACCESSWIRE) -13.16%
Sep-26-23 11:00AM	Cosmos Health Announces Expansion of Its C-Sept Brand with the Launch of C-Scrub Wash; Capitalizing on $29 Billion Global Antiseptic and Disinfectant Market (ACCESSWIRE) +9.83%
Sep-22-23 12:50PM	Cosmos Health Announces Relaunch of bio-bebe, its Proprietary Organic Infant Care & Nutrition Brand; Aims to Penetrate $103bn Global Baby Food Market (ACCESSWIRE)
Sep-20-23 11:50AM	Cosmos Health Announces Strategic Collaboration with C.A.PAPAELLINAS Group (ACCESSWIRE)
Sep-13-23 08:30AM	Cosmos Health Starts Stock Buyback Program (ACCESSWIRE)
08:00AM	BestGrowthStocks.com issues New Growth Report on Cosmos Health (News Direct)
Sep-12-23 08:30AM	Cosmos Health Introduces Guidance; Expects to Achieve Over $180M in Gross Annual Revenue and EBITDA in Excess of $20M by 2026; Recaps Significant Events Reported So Far in 2023 (ACCESSWIRE) +34.34%
Aug-15-23 07:00AM	Cosmos Health Reports Q2 2023 Financial Results; Adjusted Net Income Increases by 3550% to Surpass $3 Million for H1 2023 vs $(0.09) Million H1 2022; Book Value per Share Exceeds $4.04 (ACCESSWIRE)
Aug-08-23 09:20AM	Cosmos Health Appoints Big 4 Accounting Firm KPMG as Auditor (ACCESSWIRE)
Aug-02-23 01:15PM	Cosmos Health Continues to Expand Mediterranation Brand, Welcomes Eleonas and Olympus Mons; Boosts Exports and Secures Purchase Orders, Including from Leading Multinational Health Food Chain (ACCESSWIRE) -14.97%
Jul-25-23 09:25AM	Cosmos Health Provides Update on Recent Developments, Maintains Strong Financial Position, Reaffirms Commitment to Growth, and Highlights CEO's Continued Investment Now Exceeds $15 Million (ACCESSWIRE)
07:16AM	Daily Vickers Top Buyers & Sellers for 07/25/2023 (Argus Research)
Jul-21-23 04:00PM	Cosmos Health Inc. Announces Closing of $5.25 Million Registered Direct Offering and Concurrent Private Placement (ACCESSWIRE) -6.35%
Jul-20-23 08:00AM	Cosmos Health Inc. Announces Pricing of $5.25 Million Registered Direct Offering and Concurrent Private Placement (ACCESSWIRE) -23.39%
Jul-06-23 09:20AM	Cosmos Health Successfully Completes Acquisition of Cana Laboratories; Anticipates to Record a Substantial Gain on Bargain Purchase (ACCESSWIRE)
Jun-29-23 09:30AM	Cosmos Health Launches Chios Island, the Latest Addition to Its Mediterranation Premium Line of Supplements (ACCESSWIRE)
Jun-21-23 09:20AM	Cosmos Health Successfully Completes Second Phase of CCX0722 Development, an Innovative Product for Obesity and Weight Management: Significant Step in Bringing Product to the Multi-Billion-Dollar Market (ACCESSWIRE)
Jun-16-23 09:15AM	Cosmos Health Successfully Closes Acquisition of Assets from I. Bikas GP; Annual Revenue Projected to Grow by over $10 Million (ACCESSWIRE)
Jun-13-23 12:00PM	Cosmos Health Expands Premium Nutritional Supplements Line Mediterranation with the Launch of Terra Creta (ACCESSWIRE)
Jun-08-23 06:43AM	Daily Vickers Top Buyers & Sellers for 06/08/2023 (Argus Research)
May-31-23 09:15AM	Cosmos Health set to join Russell Microcap Index (ACCESSWIRE) +6.54%
May-25-23 11:00AM	Cosmos Health Enters into Binding Letter of Intent for the Acquisition of Docpharm GmbH., an Established German Pharmaceutical Distributor; Expected to Boost Our Annual Revenue by Approximately 32M, or 70%, by the End of 2025 vs FY 2022. (ACCESSWIRE)
May-17-23 08:00AM	Cosmos Health Reports First Quarter 2023 Financial Results; Delivers Positive Adjusted EBITDA and Significant Increase in Adjusted Net Income (ACCESSWIRE)
May-08-23 11:45AM	Cosmos Health Enters Final Phase for the Acquisition of Cana Laboratories Following Conclusion of Stock Purchase Agreement (ACCESSWIRE) +7.79%
May-03-23 01:35PM	Cosmos Health Advances Its Strategic Plan; Acquires Distressed Property Housing Operations of CosmoFarm, Expected to Generate Substantial Value for Shareholders (ACCESSWIRE)
May-01-23 06:45AM	Daily Vickers Top Buyers & Sellers for 05/01/2023 (Argus Research) -8.31%
Apr-13-23 07:00AM	Cosmos Health Ends 2022 with Transformed Balance Sheet and Achieves Positive Adjusted EBITDA for the Fiscal Year 2022 (ACCESSWIRE)
Apr-05-23 09:50AM	Cosmos Health Inc. to Participate in The Economist Annual New York-Eastern Mediterranean Business Summit on July 10th, 2023, with CEO Mr. Greg Siokas Delivering a Speech (ACCESSWIRE) -5.83%
Apr-03-23 11:55AM	Cosmos Health Inc. Enters U.S. Telehealth Space with Successful Acquisition of ZipDoctor, Inc. (ACCESSWIRE)
Mar-24-23 10:35AM	Cosmos Health Inc.'s UK Subsidiary Decahedron Ltd. Named Pharmaceutical Wholesaler of the Month in the Latest Issue of Healthcare Matters (ACCESSWIRE)
Mar-17-23 01:45PM	Cosmos Health Inc. Enters into a Definitive Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE) -6.49%
Mar-07-23 09:15AM	Cosmos Health Enters into a Material Definitive Agreement with Cana Laboratories (ACCESSWIRE) +15.06%
Mar-03-23 08:25AM	Cosmos Health Expects to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE)
Feb-15-23 03:30PM	Cosmos Health Extends its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE) +5.35%
Feb-07-23 09:15AM	Cosmos Health Announces Initial Purchase Order with Virax Biolabs for the Distribution of COVID-19 and Influenza A+B Antigen Combo Rapid Tests (ACCESSWIRE) -5.84%
08:30AM	Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM) (PR Newswire)
Feb-02-23 01:50PM	Cosmos Health Announces Application for Dual Listing on Upstream (ACCESSWIRE)
Feb-01-23 11:00AM	Cosmos Health Announces the Appointment of Nikos Bardakis, an Experienced Executive in the Pharmaceutical Industry, as Chief Operating Officer (ACCESSWIRE)
Jan-26-23 03:00PM	Cosmos Health Retains Christian Levine Law Group to Further Monitor Trading Irregularities (ACCESSWIRE)
Jan-24-23 12:40PM	Cosmos Health Announces Stock Buyback Program (ACCESSWIRE) +26.38%
Jan-20-23 01:40PM	Cosmos Health Extends and Updates its Agreement to Acquire ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp (ACCESSWIRE) +72.49%
Jan-17-23 09:15AM	Cosmos Health Provides an Update on its Debt Balance and Proforma Interest Expense (ACCESSWIRE) -5.73%
Jan-10-23 11:55AM	Cosmos Health Extends and Updates its Agreement to Acquire Cana Laboratories, a European Pharmaceutical Company (ACCESSWIRE) +5.69%
Jan-05-23 09:05AM	Cosmos Health Regains Nasdaq Minimum Bid Price Compliance (ACCESSWIRE) -7.20%
Dec-22-22 11:40AM	Cosmos Health CEO Participated in the Last Fundraising of the Company (ACCESSWIRE) -11.47%
Dec-21-22 04:10PM	Cosmos Health Inc. Announces Successful Closing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market (ACCESSWIRE) -8.45%
Dec-19-22 09:12AM	Cosmos Health Inc. Announces Pricing of $32.5 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market (ACCESSWIRE) -67.01%
Dec-15-22 07:45AM	Cosmos Holdings Inc. Changes its Name to Cosmos Health Inc. and Announces a 1-For-25 Reverse Stock Split (ACCESSWIRE)
Dec-09-22 11:30AM	Cosmos Health Retains Shareholder Intelligence Services, LLC (ACCESSWIRE)
Dec-02-22 03:10PM	Cosmos Health Provides a Summary Regarding Recent Share Activity and Reiterates its Belief and Commitment to the Financial Strength and the Growth and Profitability of the Company (ACCESSWIRE) +34.49%
Nov-29-22 05:10PM	Cosmos Health Enters the Development Phase for CCX0722, an Innovative Product for Obesity and Weight Management (ACCESSWIRE) +33.19% -22.98%
Nov-21-22 07:00AM	Cosmos Health to Sell its Sky Premium Life Luxury Food Supplement Brand on Iberian Airlines' In-flight Magazine, Ronda. (ACCESSWIRE) +21.16%
Nov-17-22 01:15PM	Cosmos Health Requests Appeal from the Nasdaq Stock Market (ACCESSWIRE) +5.73%
Nov-15-22 11:05AM	Cosmos Health Reports Third Quarter 2022 Financial Results (ACCESSWIRE) -17.57%
Nov-14-22 09:00AM	Cosmos Health Obtains Exclusive Rights to Market and Distribute Nickelodeon's SpongeBob and PAW Patrol Kids' Vitamins in Greece and Cyprus (ACCESSWIRE) +20.33%
Oct-27-22 09:50AM	Cosmos Health and Smart for Life Execute Letter of Intent for Strategic Global Co-Venture (GlobeNewswire) -15.59%
Oct-18-22 08:00AM	Cosmos Health Announces Pricing of $7.5 Million Upsized Public Offering (ACCESSWIRE) -47.33%
Oct-04-22 09:00AM	Cosmos Health Enters into a Warrant Exchange Agreement, Replacing Structured Warrants with Plain-Vanilla Warrants (ACCESSWIRE)
Sep-28-22 09:00AM	Cosmos Health Enters into Letter of Intent for the Acquisition of ZipDoctor, Inc., a Telehealth Company, from American International Holdings Corp. (ACCESSWIRE)
Sep-22-22 09:20AM	Cosmos Health Signs an Agreement with Virax Biolabs to Distribute Monkeypox Virus Real-Time PCR Detections Kits in Europe (ACCESSWIRE) +10.83%
07:30AM	Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc. (PR Newswire)

Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. It is also involved in the research and development of its business units, and acquisition of pharmaceutical companies. The firm offers over-the-counter drugs, branded and generic medicines, and dietary and vitamin supplements. The company was founded on July 21, 2009 and is headquartered in Thessaloniki, Greece.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Siokas Grigorios	Chief Executive Officer	Feb 16 '24	Buy	0.83	60,000	49,806	1,394,597	Feb 21 10:21 AM
Siokas Grigorios	Chief Executive Officer	Oct 12 '23	Buy	23.66	6,712	158,806	1,334,597	Oct 12 09:43 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COSM

Cosmos Health Inc

Upgrade your FINVIZ experience